Innovative Eyewear Inc. Common Stock (LUCY)
Fast GrowerFairStock Score: 56/100 — STEADY
Key Financials
| Current Price | $0.93 |
| Market Cap | $7M |
| P/E Ratio | -0.6 |
| ROE | -102.4% |
| Dividend Yield | —% |
| Sector | Healthcare |
Strengths
- Revenue growth of 39.0% demonstrates strong top-line momentum
Concerns
- Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions
- Altman Z-Score of -0.5 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
Innovative Eyewear Inc. Common Stock is a micro-cap healthcare company valued at $7 million. Revenue stands at $3 million. From a quality standpoint, Innovative shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and distressed Altman Z-Score of -0.5 warrants caution. Growth dynamics show revenue growing at 39.0% and profit growth of 12.0%. Our composite FairStock Score of 56/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Innovative's 39% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer